BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, Currey JM, Iwanaga N, He J, Mi R, Han K, Midkiff CC, Alam MA, Aktas BH, Heide RSV, Veazey R, Piedimonte G, Maness NJ, Ergün S, Mauvais-Jarvis F, Rappaport J, Kolls JK, Qin X. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 2021;11:8076-91. [PMID: 34335981 DOI: 10.7150/thno.61810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Pennitz P, Kirsten H, Friedrich VD, Wyler E, Goekeri C, Obermayer B, Heinz GA, Mashreghi MF, Büttner M, Trimpert J, Landthaler M, Suttorp N, Hocke AC, Hippenstiel S, Tönnies M, Scholz M, Kuebler WM, Witzenrath M, Hoenzke K, Nouailles G. A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics. Eur Respir Rev 2022;31:220056. [PMID: 35896273 DOI: 10.1183/16000617.0056-2022] [Reference Citation Analysis]
2 Kansakar U, Gambardella J, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Matarese A, Santulli G. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections. IJMS 2022;23:10242. [DOI: 10.3390/ijms231810242] [Reference Citation Analysis]
3 Finsterer J, Scorza FA. Febrile Seizures in COVID-19 Patients Are Multifactorial. J Child Neurol 2022;:8830738221114492. [PMID: 35876341 DOI: 10.1177/08830738221114492] [Reference Citation Analysis]
4 Izzo R, Trimarco V, Mone P, Aloè T, Marzani MC, Diana A, Fazio G, Mallardo M, Maniscalco M, Marazzi G, Messina N, Mininni S, Mussi C, Pelaia G, Pennisi A, Santus P, Scarpelli F, Tursi F, Zanforlin A, Santulli G, Trimarco B. Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The Nationwide Multicenter LINCOLN Study. Pharmacol Res 2022;:106360. [PMID: 35868478 DOI: 10.1016/j.phrs.2022.106360] [Reference Citation Analysis]
5 Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, Yusof AHA, Sagadevan S, Hazafa A, Uddin J, Khan A, Al-harrasi A. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules 2022;12:971. [DOI: 10.3390/biom12070971] [Reference Citation Analysis]
6 Narasimhulu CA, Singla DK. Mechanisms of COVID-19 Pathogenesis in Diabetes. Am J Physiol Heart Circ Physiol 2022. [PMID: 35776683 DOI: 10.1152/ajpheart.00204.2022] [Reference Citation Analysis]
7 Tiwari S, Goel G, Kumar A. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. Int Rev Immunol 2022;:1-20. [PMID: 35757923 DOI: 10.1080/08830185.2022.2089666] [Reference Citation Analysis]
8 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 de Vries MP, Mohammadnia N, Simsek S, Schoorl M. Eosinopenia and increased markers of endothelial damage are characteristic of COVID-19 infection at time of hospital admission. Scand J Clin Lab Invest 2022;:1-6. [PMID: 35621384 DOI: 10.1080/00365513.2022.2079095] [Reference Citation Analysis]
10 Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, Papaioannou TG, Haidich A, Tsaousi G, Vasileios N, Vissaria S, Charalambous G, Rapti V, Raftopoulou S, Syrigos K, Tsioufis C, Tousoulis D, Vavuranakis M. Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Schmit T, Guo K, Tripathi JK, Wang Z, McGregor B, Klomp M, Ambigapathy G, Mathur R, Hur J, Pichichero M, Kolls J, Khan MN. Interferon-γ promotes monocyte-mediated lung injury during influenza infection. Cell Rep 2022;38:110456. [PMID: 35235782 DOI: 10.1016/j.celrep.2022.110456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bertozzi S, Taricani R, Tulissi I, Patusso F, Amura S, Londero AP. Redesigning doctor-patient relationship in the private health care during COVID-19 pandemic: Retrospective cohort study. Medicine (Baltimore) 2022;101:e28781. [PMID: 35147107 DOI: 10.1097/MD.0000000000028781] [Reference Citation Analysis]
13 Dutt TS, LaVergne SM, Webb TL, Baxter BA, Stromberg S, McFann K, Berry K, Tipton M, Alnachoukati O, Zier L, Ebel G, Dunn J, Henao-Tamayo M, Ryan EP. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. J Immunol 2022;208:685-96. [PMID: 34987111 DOI: 10.4049/jimmunol.2100830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Jessop F, Schwarz B, Scott D, Roberts LM, Bohrnsen E, Hoidal JR, Bosio CM. Impairing RAGE signaling promotes survival and limits disease pathogenesis following SARS-CoV-2 infection in mice. JCI Insight 2022;7:e155896. [DOI: 10.1172/jci.insight.155896] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
16 Theofilis P, Sagris M, Antonopoulos AS, Oikonomou E, Tsioufis C, Tousoulis D. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19. Int J Mol Sci 2021;22:11170. [PMID: 34681830 DOI: 10.3390/ijms222011170] [Reference Citation Analysis]
17 Spier AB, Evans CE. Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs. Front Cardiovasc Med 2021;8:745906. [PMID: 34621804 DOI: 10.3389/fcvm.2021.745906] [Reference Citation Analysis]
18 Mangge H, Kneihsl M, Schnedl W, Sendlhofer G, Curcio F, Domenis R. Immune Responses against SARS-CoV-2-Questions and Experiences. Biomedicines 2021;9:1342. [PMID: 34680460 DOI: 10.3390/biomedicines9101342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice. Arterioscler Thromb Vasc Biol 2021;41:2773-85. [PMID: 34496633 DOI: 10.1161/ATVBAHA.121.316925] [Reference Citation Analysis]